Sipatrigine is primarily investigated for its neuroprotective properties, making it a potential candidate for treating conditions involving neuronal damage. It has shown promise in mitigating the effects of stroke by reducing the extent of brain injury following ischemic events. The compound works by blocking sodium and calcium channels, which helps in preventing the cascade of events leading to cell death in neurons. Additionally, sipatrigine is being studied for its potential in managing chronic pain conditions, particularly neuropathic pain, where it may help in modulating pain signals. Its ability to protect nerve cells from damage also opens avenues for research in neurodegenerative diseases such as Alzheimer's and Parkinson's, where neuronal loss is a significant concern.